Orbimed Advisors - I MAB ownership

I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 81 filers reported holding I MAB in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of I MAB
ValueSharesWeighting
Q1 2022$1,805,000
-65.7%
111,1200.0%0.03%
-57.4%
Q4 2021$5,266,000
-34.6%
111,1200.0%0.07%
-23.6%
Q3 2021$8,055,000
-13.7%
111,1200.0%0.09%
-5.3%
Q2 2021$9,329,000
+936.6%
111,120
+498.5%
0.09%
+1075.0%
Q1 2021$900,000
-96.9%
18,565
-96.9%
0.01%
-96.8%
Q4 2020$28,576,000
+0.3%
606,0700.0%0.25%
-30.2%
Q3 2020$28,503,000606,0700.36%
Other shareholders
I MAB shareholders Q1 2021
NameSharesValueWeighting ↓
EDBI Pte Ltd 222,136$293,2200.32%
HHLR ADVISORS, LTD. 6,909,220$9,120,1700.20%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 310,499$409,8590.14%
Maso Capital Partners Ltd 100,000$1320.07%
Diametric Capital, LP 122,953$162,2970.07%
Artal Group S.A. 850,000$1,1220.05%
GSA CAPITAL PARTNERS LLP 195,546$2580.02%
Headlands Technologies LLC 7,394$9,7600.01%
Temasek Holdings (Private) Ltd 566,650$747,9780.00%
PRELUDE CAPITAL MANAGEMENT, LLC 39,471$52,1020.00%
View complete list of I MAB shareholders